– La primera de su clase en el mundo: La Administración Nacional de Productos Médicos de China ha aprobado para ensayos clínicos la vacuna recombinante multivalente de proteína de la COVID-19 contra las variantes XBB de WestVac Biopharma/West China Medical Center, Sichuan University…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.